Equipment for haematology studies

Why it matters

Why does coagulation testing need faster turnaround in haematology trials?
Trials of anticoagulants and clotting disorders often need coagulation results within minutes to make a same-visit dosing decision, since the acceptable range for safe dosing is narrow and a delay increases risk. Point-of-care coagulation and blood analysers let sites act immediately rather than waiting on a central lab.

CAR-T and cell therapy have brought oncology-grade cold chain into haematology
Many blood cancers, particularly leukaemias and lymphomas, are now treated with CAR-T and other cell therapies that require the same cryogenic storage and vein-to-vein timing discipline used in oncology cell therapy trials. Haematology trial teams working with these therapies need the same ultra-low temperature freezers and continuous monitoring equipment.

Rare blood disorders mean small, globally dispersed trials
Conditions like haemophilia and sickle cell disease affect relatively small, often geographically scattered patient populations, which means haematology trials frequently run across many countries with only a handful of patients per site. That makes flexible, rapid equipment provisioning more important than the large standardised fleets a bigger trial might use.

What we do

Our global distribution network puts calibrated equipment on site for haematology studies anywhere in the world, whenever it's needed. Coagulation and cell monitoring covers POCT blood analysers. Cell therapy supply covers cold chain and cryogenic storage equipment. Day-to-day site operations covers centrifuges, infusion pumps, refrigerators, freezers, thermometers, temperature dataloggers, and scales. Everything is available fully calibrated and ready to use. If you require equipment supply for a haematology study, get in touch.